Market closedNon-fractional
Progyny/PGNY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Progyny
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Ticker
PGNY
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Providers and Services
Headquarters
New York, United States
Employees
565
Website
www.progyny.com
Progyny Metrics
BasicAdvanced
$2.7B
Market cap
46.87
P/E ratio
$0.61
EPS
1.51
Beta
-
Dividend rate
Price and volume
Market cap
$2.7B
Beta
1.51
Financial strength
Current ratio
3.31
Quick ratio
3.249
Long term debt to equity
2.936
Total debt to equity
3.375
Management effectiveness
Return on assets (TTM)
5.69%
Return on equity (TTM)
12.30%
Valuation
Price to earnings (TTM)
46.87
Price to revenue (TTM)
2.469
Price to book
4.82
Price to tangible book (TTM)
4.92
Price to free cash flow (TTM)
14.377
Growth
Revenue change (TTM)
26.94%
Earnings per share change (TTM)
41.86%
3-year revenue growth (CAGR)
42.13%
3-year earnings per share growth (CAGR)
1.67%
What the Analysts think about Progyny
Analyst Ratings
Majority rating from 10 analysts.
Progyny Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$278M
3.00%
Net income
$17M
25.37%
Profit margin
6.04%
21.77%
Progyny Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.15
$0.16
$0.13
$0.17
-
Expected
$0.10
$0.12
$0.11
$0.13
$0.17
Surprise
43.84%
36.59%
21.50%
28.57%
-
Progyny News
AllArticlesVideos
Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report
GlobeNewsWire·3 days ago
Assisted Reproductive Technology Market Report 2024-2033: Vitrolife Leads the Competition with 9.8% Share, Followed by Ferring, and Progyny
GlobeNewsWire·2 weeks ago
Progyny, Inc. to Host 2024 Inaugural Investor Day
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Progyny stock?
Progyny (PGNY) has a market cap of $2.7B as of July 27, 2024.
What is the P/E ratio for Progyny stock?
The price to earnings (P/E) ratio for Progyny (PGNY) stock is 46.87 as of July 27, 2024.
Does Progyny stock pay dividends?
No, Progyny (PGNY) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Progyny dividend payment date?
Progyny (PGNY) stock does not pay dividends to its shareholders.
What is the beta indicator for Progyny?
Progyny (PGNY) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Progyny stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.